R. P. Baum

1.1k total citations
77 papers, 644 citations indexed

About

R. P. Baum is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, R. P. Baum has authored 77 papers receiving a total of 644 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Radiology, Nuclear Medicine and Imaging, 25 papers in Pulmonary and Respiratory Medicine and 21 papers in Oncology. Recurrent topics in R. P. Baum's work include Radiopharmaceutical Chemistry and Applications (28 papers), Medical Imaging and Pathology Studies (16 papers) and Neuroendocrine Tumor Research Advances (14 papers). R. P. Baum is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (28 papers), Medical Imaging and Pathology Studies (16 papers) and Neuroendocrine Tumor Research Advances (14 papers). R. P. Baum collaborates with scholars based in Germany, United States and Canada. R. P. Baum's co-authors include G. Hör, A. Hertel, A. Encke, Matthias Lorenz, M Mezzetti, D. Hellwig, Agatha Schwarz, A. Niesen, K. H. Usadel and T.R. Sykes and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and European Journal of Cancer.

In The Last Decade

R. P. Baum

73 papers receiving 604 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. P. Baum Germany 14 368 237 177 122 113 77 644
Geert Ensing Netherlands 8 302 0.8× 306 1.3× 348 2.0× 204 1.7× 97 0.9× 15 647
John O. Olsen United States 13 348 0.9× 227 1.0× 144 0.8× 82 0.7× 293 2.6× 42 877
L. Gogou Greece 9 202 0.5× 127 0.5× 128 0.7× 57 0.5× 65 0.6× 13 417
Berlinda J. de Wit–van der Veen Netherlands 16 420 1.1× 361 1.5× 186 1.1× 100 0.8× 183 1.6× 50 779
Marina Orevi Israel 14 152 0.4× 225 0.9× 156 0.9× 113 0.9× 216 1.9× 23 577
Thorsten Pöppel Germany 15 221 0.6× 364 1.5× 280 1.6× 158 1.3× 159 1.4× 24 694
Dave Yamauchi United States 16 433 1.2× 320 1.4× 51 0.3× 42 0.3× 158 1.4× 35 713
Emmanuel Deshayes France 20 552 1.5× 300 1.3× 276 1.6× 67 0.5× 353 3.1× 75 1.2k
J Genollá Spain 11 86 0.2× 198 0.8× 134 0.8× 40 0.3× 82 0.7× 37 447
Thomas K. Rhee United States 13 370 1.0× 197 0.8× 261 1.5× 105 0.9× 203 1.8× 18 877

Countries citing papers authored by R. P. Baum

Since Specialization
Citations

This map shows the geographic impact of R. P. Baum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. P. Baum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. P. Baum more than expected).

Fields of papers citing papers by R. P. Baum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. P. Baum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. P. Baum. The network helps show where R. P. Baum may publish in the future.

Co-authorship network of co-authors of R. P. Baum

This figure shows the co-authorship network connecting the top 25 collaborators of R. P. Baum. A scholar is included among the top collaborators of R. P. Baum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. P. Baum. R. P. Baum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Wolin, Edward M., Beth Chasen, M. Kulke, et al.. (2017). NETTER-1 Phase III Trial : Recent Findings on Quality of Life in Patients with Midgut Neuroendocrine Tumors. Neuroendocrinology. 105. 257–257. 2 indexed citations
4.
Kotzerke, J., Liane Oehme, Oliver Lindner, et al.. (2015). Positronenemissionstomographie 2013 in Deutschland: Ergebnisse der erhebung und standortbestimmung. Nuklearmedizin - NuclearMedicine. 49(2). 58–64. 2 indexed citations
5.
Scheuermann, E., et al.. (2015). Correction of Renal Anaemia by Recombinant Human Erythropoietin: Effects on Myocardial Function. Contributions to nephrology. 66. 176–184.
6.
Sánchez, Ignacio, et al.. (2004). Radioinmunolocalización de tumores de cabeza y cuello con un nuevo anticuerpo monoclonal contra el receptor del EGF. Resultados preliminares. Revista Española de Medicina Nuclear. 23(4). 273–278. 1 indexed citations
7.
Lukač, Josip, et al.. (1999). Immunoscintigraphy with 99Tcm-labelled monoclonal anti-CEA BW 431/26 antibodies in patients with suspected recurrent and metastatic colorectal carcinoma. Nuclear Medicine Communications. 20(9). 859–866. 3 indexed citations
8.
Baum, R. P., et al.. (1999). Bone marrow immunoscintigraphy for the detection of skeletal metastases in patients with breast cancer. Nuclear Medicine Communications. 20(2). 135–144. 4 indexed citations
9.
Hör, G., W. T. Kranert, F. D. Maul, et al.. (1998). Gated metabolic positron emission tomography (GAPET) of the myocardium. Nuclear Medicine Communications. 19(6). 535–546. 15 indexed citations
10.
11.
Baum, R. P., et al.. (1998). Metabolic (PET) and receptor (SPET) imaging of well- and less well-differentiated tumours. Nuclear Medicine Communications. 19(7). 641–648. 60 indexed citations
12.
McQuarrie, S.A., R. P. Baum, A. Niesen, et al.. (1997). Pharmacokinetics and radiation dosimetry of 99Tcm-labelled monoclonal antibody B43.13 in ovarian cancer patients. Nuclear Medicine Communications. 18(9). 878–886. 20 indexed citations
13.
Kiefer, Jan, et al.. (1994). [Immunoscintigraphy of carcinomas in the area of the head-neck with technetium-99m marked monoclonal antibody 174H.64. A new diagnostic procedure].. PubMed. 42(9). 546–52. 2 indexed citations
14.
Klepzig, H, et al.. (1994). [Clinical relevance of equilibrium radionuclide ventriculography].. PubMed. 89(8). 442–52. 1 indexed citations
15.
Baum, R. P., A. Niesen, A. Hertel, et al.. (1994). Activating anti-idiotypic human anti-mouse antibodies for immunotherapy of ovarian carcinoma. Cancer. 73(S3). 1121–1125. 58 indexed citations
16.
Baum, R. P., A. Niesen, A. Hertel, et al.. (1994). Initial clinical results with technetium-99m-labeled ll2 monoclonal antibody fragment in the radioimmunodetection of b-cell lymphomas. Cancer. 73(S3). 896–899. 29 indexed citations
17.
Boeckmann, W., H. Schuldes, Wolfgang Kramer, et al.. (1990). Immunoscintigram of urinary bladder carcinoma. Evidence of specific type of binding of the labelled MAB BW 431/26 in the tumoral tissue by means of immunohistochemistry and uptake measurements. 29(2). 35–36. 2 indexed citations
18.
Hartmann, Andreas, Joost Frenkel, R. Hopf, et al.. (1990). Is technetium-99 m-pyrophosphate scintigraphy valuable in the diagnosis of cardiac amyloidosis?. International journal of cardiac imaging. 5(4). 227–231. 8 indexed citations
19.
Baum, R. P., A. Hertel, Matthias Lorenz, et al.. (1989). 99Tcm-labelled anti-CEA monoclonal antibody for tumour immunoscintigraphy. Nuclear Medicine Communications. 10(5). 345–352. 76 indexed citations
20.
Lorenz, Matthias, C. Hottenrott, R. P. Baum, et al.. (1987). CA-19–9 and CEA in the differential diagnosis of isolated liver metastases compared to clinical laboratory tests. Nuclear Medicine Communications. 8(10). 787–796. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Geert Ensing Breakdown of academic impact, for papers by John O. Olsen Breakdown of academic impact, for papers by L. Gogou Breakdown of academic impact, for papers by Berlinda J. de Wit–van der Veen Breakdown of academic impact, for papers by Marina Orevi Breakdown of academic impact, for papers by Thorsten Pöppel Breakdown of academic impact, for papers by Dave Yamauchi Breakdown of academic impact, for papers by Emmanuel Deshayes Breakdown of academic impact, for papers by J Genollá Breakdown of academic impact, for papers by Thomas K. Rhee
Rankless by CCL
2026